Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 Last 

California

La Jolla California 92093-0698

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Indiana

UPDATED

Indianapolis Indiana 46237

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Maryland

Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Bethesda Maryland 20817

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

New York

New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Tennessee

Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Kingsport Tennessee 37660

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Texas

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Washington

Seattle Washington 98101

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Austria

Eggenburg 3730

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Wien 1030

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Wien 1090

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Belgium

Arlon 6700

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Liege 4000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Liège 4000

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Bulgaria

Plovdiv 4004

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Shumen 9700

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Sofia 1527

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Sofia 1756

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Sofia 1303

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

China

Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

View More ▼

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Fuzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Guangzhou

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Tianjin Tianjin 300060

Patients are needed to participate in a clinical research study evaluating GW003 for the treatment of Chemotherapy-induced Neutropenia or Metastatic Tumors

Wuhan

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Xiamen

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Zhejiang

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Czech Republic

Chomutov 430 12

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Horovice 268 31

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Plzen 304 60

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Praha 10 100 34

A clinical study for patients with Chemotherapy-induced Febrile Neutropenia

Denmark

Aalborg 9000

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Odense 5000

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

France

Paris 75015

A clinical research study of 18F-FDG PET Scan

Georgia

Batumi 6000

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Tbilisi 0112

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Tbilisi 0131

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Tbilisi 0144

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Tbilisi 179

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Germany

Aurich

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Bad Soden a. T.

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

Berlin

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

First 1 2 3 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.